The simplified comparison is this: Semaglutide: GLP-1 receptor activity Tirzepatide: GIP and GLP-1 receptor activity Retatrutide: GIP, GLP-1, and glucagon receptor activity under clinical investigation More receptor activity does not automatically mean a medication is better for every patient
Zepbound activates GLP-1 and GIP receptors simultaneously-reducing appetite significantly within days, slowing gastric emptying by approximately 40%, and producing average weight loss of up to 21% by week 72
In most cases, the medical history provides clues, but never the final answer
At this point, addressing underlying conditions, such as liver disease, can typically treat the root cause of high bilirubin
03 Wrong BAC water volume If you added the wrong volume, recalculate the new concentration before drawing
If you are unsure about portions, a registered dietitian can help tailor a plan to your medical history and preferences